| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/02/2013 | US8476262 Cyanopyrroles |
| 07/02/2013 | US8476230 Insulinotropic complex using an immunoglobulin fragment |
| 07/02/2013 | CA2748249C Cyclic amine compounds |
| 07/02/2013 | CA2590549C Therapeutic agent for polycystic ovary syndrome (pcos) |
| 07/02/2013 | CA2251009C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/27/2013 | WO2013092269A1 Pharmaceutical compositions comprising glitazones and nrf2 activators |
| 06/27/2013 | WO2013091539A1 Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
| 06/27/2013 | US20130165428 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/26/2013 | EP2607358A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid |
| 06/26/2013 | EP2606908A1 Novel pharmaceutical composition for a long acting growth hormone fusion protein (LAGH) |
| 06/26/2013 | EP2605798A1 Gene therapy composition for use in diabetes treatment |
| 06/26/2013 | CN103180309A Antagonist for mutated androgen receptor |
| 06/26/2013 | CN103173477A Method for stably expressing recombined human serum albumin and human parathyroid hormone (1-34)ab diad fusion protein by using saccharomyces cerevisiae |
| 06/26/2013 | CN103172635A Piperazine or piperidine compound as well as salts, intermediates, preparation method and application thereof |
| 06/26/2013 | CN103172633A Compound, and preparation method and application thereof |
| 06/26/2013 | CN103169984A N-terminal derivatisation of proteins with polysaccharides |
| 06/26/2013 | CN103169864A Fluid-increasing decoction formula granules and preparation method, application and detection method thereof |
| 06/26/2013 | CN102716091B Method for preparing metoprolol tartrate particles |
| 06/26/2013 | CN102430038B Composition for improving blood testosterone, and composition-containing preparation and preparation method thereof |
| 06/26/2013 | CN102397255B Progesterone ethosome, and preparation method and application thereof |
| 06/26/2013 | CN101744996B Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof |
| 06/26/2013 | CN101744995B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof |
| 06/26/2013 | CN101744994B Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof |
| 06/26/2013 | CN101744990B Method for individually extracting ginseng, radix ophiopogonis and schisandra chinensis and preparation thereof |
| 06/25/2013 | US8470295 Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs |
| 06/25/2013 | CA2513743C Reducing culling in herd animals growth hormone releasing hormone (ghrh) |
| 06/20/2013 | WO2013086980A1 Sulfonylurea guanidine, preparation method and use thereof |
| 06/20/2013 | WO2013086927A1 Human insulin analogue and acylated derivative thereof |
| 06/20/2013 | CA2858253A1 Human insulin analogue and acylated derivative thereof |
| 06/19/2013 | EP2604594A1 1,2,4-Triazole derivatives as ghrelin analogue ligands of GHS receptors |
| 06/19/2013 | CN103159680A Imidazole diketone compound and application thereof |
| 06/19/2013 | CN103159651A Sulfonylurea guanidine and preparation method and application thereof |
| 06/19/2013 | CN103157096A Teriparatide sustained-release microsphere and preparation method thereof |
| 06/19/2013 | CN103156700A Vagina embolism of regulating yak reproduction and preparation method thereof |
| 06/19/2013 | CN102488210B Genistein hydrogel compound and its preparation method |
| 06/19/2013 | CN102335269B Aromatase inhibitor |
| 06/19/2013 | CN102228454B Brain targeting via olfactory pathway fragrant essential oil compound and monomer pharmaceutical composition with functions for preventing and treating brain atrophy and activating brain cells |
| 06/18/2013 | US8466139 Formulation |
| 06/18/2013 | CA2418144C Urocortin proteins and uses thereof |
| 06/13/2013 | WO2013085954A1 Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
| 06/13/2013 | WO2013084138A1 Cyclic urea derivatives as androgen receptor antagonists |
| 06/13/2013 | WO2013083568A1 6,7-dihydro-5h-benzo[7]annulene derivatives, methods for the production thereof, pharmaceutical preparations that contain said 6,7-dihydro-5h-benzo[7]annulene derivatives, and use thereof to produce drugs |
| 06/13/2013 | WO2013082756A1 Phosphate transport inhibitors ii |
| 06/13/2013 | WO2013082751A1 Phosphate transport inhibitors i |
| 06/13/2013 | US20130150374 Arylalkylamine compound and process for preparing the same |
| 06/13/2013 | CA2858265A1 6,7-dihydro-5h-benzo[7]annulene derivatives, methods for the production thereof, pharmaceutical preparations that contain said 6,7-dihydro-5h-benzo[7]annulene derivatives, and use thereof to produce drugs |
| 06/12/2013 | EP2601949A2 Pharmaceutical compositions |
| 06/12/2013 | EP2601946A1 Treatment and prevention of diseases related to oxidative stress |
| 06/12/2013 | EP2600865A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 06/12/2013 | CN1461310B ANtibodies that bind human interleukin-18 and methods of making and using |
| 06/12/2013 | CN103146637A Method for preparation of flavone by culturing radix puerariae cells |
| 06/12/2013 | CN103145773A Crystalline solvates and complexes of (IS) -1, 5-anhydro-L-C- (3- ( (phenyl) methyl) phenyl) -D-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes |
| 06/12/2013 | CN103145738A Imidazo [2,1-b] thiayole derivatives as SIRTUIN modulating compounds |
| 06/12/2013 | CN103145712A Substituted 8-[6-amino-3-pyridyl]xanthenes |
| 06/12/2013 | CN103142927A Traditional Chinese medicine formula for preserving health and treating multiple diseases |
| 06/12/2013 | CN103142800A Hyperthyroidism treatment medicine and its preparation method |
| 06/12/2013 | CN103142647A Lanthanum hydroxide therapeutical effects on hyperphosphatemia and relative diseases |
| 06/12/2013 | CN103142553A Calcitriol sustained-release capsule and preparation method thereof |
| 06/12/2013 | CN103142503A Alfacalcidol sustained-release granule and preparation method thereof |
| 06/12/2013 | CN103141536A Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom |
| 06/12/2013 | CN102106805B Cymipristone solid preparation and preparation methods thereof |
| 06/12/2013 | CN101790376B Tsh receptor antagonizing tetrahydroquinoline compounds |
| 06/12/2013 | CN101018546B (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/12/2013 | CN101006099B Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 06/11/2013 | US8461152 Arylcyclohexylethers of dihydrotetraazabenzoazulenes |
| 06/11/2013 | US8461139 Oral suspension of prednisolone acetate |
| 06/06/2013 | WO2013081118A1 Compound having read-through activity |
| 06/05/2013 | CN103140236A Growth hormone polypeptides and methods of making and using same |
| 06/05/2013 | CN103127527A Treatment of diabetes mellitus by taking insulin PEGylation derivative as active component |
| 06/05/2013 | CN103127331A Pharmaceutical composition, and preparation method and application thereof |
| 06/05/2013 | CN103127207A Method for increasing astragaloside content in radix astragali total extract by acid catalysis |
| 06/05/2013 | CN103127152A Application of Gypensapogenin A in insulin secretion medicines |
| 06/05/2013 | CN103127083A Application of Aphanamixoid A to insulin secretion stimulating medicine |
| 06/05/2013 | CN103127068A Application of Eryngiolide A in medicines promoting insulin secretion |
| 06/05/2013 | CN103127066A Application of Eryngiolide A in medicines curing rarefaction of bone caused by lack of antiestrogen |
| 06/05/2013 | CN102634432B Desert cistanche and black rice health maintenance wine and production method thereof |
| 06/05/2013 | CN102416001B Octreotide acetate freeze-dried powder injection for injection and preparation method thereof |
| 06/05/2013 | CN101967168B Triterpenoid saponin derivative and preparation method and application thereof |
| 06/05/2013 | CN101744999B Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof |
| 06/05/2013 | CN101744997B Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof |
| 06/05/2013 | CN101744986B Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof |
| 06/05/2013 | CN101227892B Buccal delivery system |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | CA2457801C Streptococcus thermophilus strain and use thereof |
| 05/30/2013 | WO2013076516A1 1,4- dihydropyridine derivatives with hsp modulating activity |
| 05/30/2013 | WO2012174478A9 Stable formulations of a hyaluronan-degrading enzyme |
| 05/30/2013 | WO2012158962A3 Improved peptide pharmaceuticals |
| 05/30/2013 | CA2854252A1 1,4-dihydropyridine derivatives with hsp modulating activity |
| 05/29/2013 | EP2597095A1 Fused heterocyclic compound and application thereof |
| 05/29/2013 | EP2595661A1 Growth hormone conjugates |
| 05/29/2013 | CN1911965B Binding domain-immunoglobulin fusion proteins |
| 05/29/2013 | CN102719397B Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus) |
| 05/29/2013 | CN101883556B Transdermal delivery system for hormones and steroids |
| 05/29/2013 | CN101669934B application of mango aglycone in preparing medicine for obesity |
| 05/28/2013 | US8450272 Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes |
| 05/28/2013 | CA2559748C Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 05/28/2013 | CA2240292C Recombinant fusion proteins to growth hormone and serum albumin |
| 05/23/2013 | WO2013071355A1 Soluble mediator |
| 05/23/2013 | CA2852133A1 Soluble mediator |